Portfolio (Quarterly)
Guide ↗
Aisling Capital Management LP
· CIK 0001766721| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BBIO | BridgeBio Pharma Inc. (BBIO) | Healthcare | 5,089,611.0 | $389.3M | 81.29% | NEW | — | $76.49 | -13.3% |
| 2 | SNDX | Syndax Pharmaceuticals, Inc. (SNDX) | Healthcare | 1,316,806.0 | $27.7M | 5.78% | NEW | — | $21.01 | -14.5% |
| 3 | GLUE | Monte Rosa Therapeutics Inc (GLUE) | Healthcare | 1,472,331.0 | $23.1M | 4.82% | NEW | — | $15.68 | -25.3% |
| 4 | BCAX | Bicara Therapeutics Inc. (BCAX) | Healthcare | 568,919.0 | $9.6M | 2.00% | NEW | — | $16.83 | +17.5% |
| 5 | CMPS | Compass Pathways Plc (CMPS) | Healthcare | 1,198,418.0 | $8.3M | 1.73% | NEW | — | $6.90 | +89.7% |
| 6 | — | BridgeBio Oncology Therapeutics (BBOT) | — | 564,625.0 | $7.1M | 1.48% | NEW | — | $12.52 | — |
| 7 | CALC | CalciMedica, Inc. (CALC) | Healthcare | 521,114.0 | $3.4M | 0.72% | NEW | — | $6.59 | -74.1% |
| 8 | SRRK | Scholar Rock Holding Corporation (SRRK) | Healthcare | 77,031.0 | $3.4M | 0.71% | NEW | — | $44.05 | +10.4% |
| 9 | BMEA | Biomea Fusion Inc (BMEA) | Healthcare | 2,048,757.0 | $2.5M | 0.53% | NEW | — | $1.24 | +20.2% |
| 10 | URGN | Urogen Pharma Ltd. (URGN) | Healthcare | 108,000.0 | $2.5M | 0.53% | NEW | — | $23.42 | +76.0% |
| 11 | ACRS | Aclaris Therapeutics Inc (ACRS) | Healthcare | 434,455.0 | $1.3M | 0.27% | NEW | — | $3.01 | +78.7% |
| 12 | — | Marker Therapeutics, Inc. (MRKR) | — | 325,370.0 | $485K | 0.10% | NEW | — | $1.49 | — |
| 13 | — | OnKure Therapeutics, Inc. (OKUR) | — | 88,607.0 | $257K | 0.05% | NEW | — | $2.90 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%